On the recordMarch 8, 2011
I would actually argue it probably will kill a lot of medical innovation.
Source
congress.govI would actually argue it probably will kill a lot of medical innovation.
Kirk warns that IPAB could stifle medical innovation due to bureaucratic constraints.
Share
More from Mark Kirk
I look at the Adam Szubin problem not just in the context of are we serious about terrorism...
I am always concerned about what our policy is in the world as it relates to how we deal with achieving the release of hostages.
It is imperative for the Committee, in its oversight responsibilities, get to the bottom of exactly how much cash has been transferred.
I am dismayed that... not once did the Administration ever share that this was a pending item and/or that it was in the midst of a potential negotiation.